BETTER SAFER CRYO - PowerPoint PPT Presentation

1 / 29
About This Presentation
Title:

BETTER SAFER CRYO

Description:

The effect of temperature on Factor VIII levels in whole blood ... Elution patterns of citrated and heparinized plasma following gel chromatography ... – PowerPoint PPT presentation

Number of Views:78
Avg rating:3.0/5.0
Slides: 30
Provided by: Rece59
Category:
Tags: better | cryo | safer | elution

less

Transcript and Presenter's Notes

Title: BETTER SAFER CRYO


1
BETTER SAFER CRYO
  • Is it possible?
  • Is it cheaper?

2
BETTER CRYO
  • YES!

3
MANY VARIABLES
  • Blood group
  • Time to freeze/thaw
  • Rate of freeze/thaw
  • Temperature
  • Anticoagulant

4
Loss of Factor VIII procoagulant activity over
time
Rock 1983
5
The effect of temperature on Factor VIII levels
in whole blood
6
  • Leucoreduction 24 hr plasma hold
  • A trade off
  • Logistics vs F VIII recovery

7
CRYO
  • FREEZE PLASMA
  • THAW
  • CENTRIFUGE
  • CRYOPRECIPITATE
  • 4 plasma proteins
  • Min 80 U FVIII
  • 150 mg fibrinogen

8
Factor VIII Activity in cryoprecipitate and
supernatant plasma during 4C thawing
9
  • Thaw Siphon
  • heparin
  • Additives
  • citrate

10
Purification of FVIII 1970s
  • Run plasma on column
  • Obtain FVII with vWF
  • Split FVIII off using CaCl2
  • BUT
  • What if you never removed citrate?
  • chelates calcium
  • Use heparin as anticoagulant
  • Calcium is part of the FVIII molecule
  • ARTIFACT

11
Structure of Factor VIII
12
  • Improved yields of factor VIII from
  • Heparinized plasma
  • Vox Sang 1979 36 294 300
  • Rock G., Cruickshank WH.,
  • Tackaberry ES., Palmer DS.
  • IP 531 U/L 215 U/L

13
  THE EFFECT OF IONIZED CALCIUM LEVELS ON FVIIIC
ACTIVITY      
 
14
Elution patterns of citrated and heparinized
plasma following gel chromatography
Citrate
Heparin
15
The effect of storage on Factor VIII Activity in
Heparinized Plasma
16
Heparin
Citrate
17
Comparison of Factor VIII Activity of Plasma and
Cryoprecipitate from Blood Collected into Various
Anticoagulants
SD (pgt0.005) from standard CPD values 250 ml each
18
CRYO
  • Can be further processed in blood bank to
    intermediate purity
  • Products can be sterilized

19
IN VIVO
  • Cryo ½ life hr
  • Heparin 1.14 6.8
  • CPD 1.13 6.0

20
The effects of heparin on Factor VIII
purification
HEPARIN
primary anticoagulant
added to citrate plasma
OR
enhances cryoprecipitability
AND
permits Clg purification step
21
Flow scheme for purification of Factor VIII from
citrated plasma following addition of heparin and
using a cold insoluble globulin precipitate step
Freeze -80C Thaw 4C x 75 min
Spin 7,000 x g, 7 min at 0C
Drain
1 Total FVIII 1,633 units Total Fibrinogen
4,404 MG Total Protein 131,520 MG
Fresh CPD plasma1 made to 1 unit heparin per mL
2 Total FVIII 1,325 units Total Fibrinogen 424
MG Total Protein 4,770 MG
Supernatant of Cryoprecipitate
Cryoprecipitate2
Resolubilize 37C, 2-5 min Add 2.5mL CSH
buffer Incubate 0C x 2hr
Spin 7,000 x g, 7 min at 0C
Drain
Cold Soluble Supernatant
Cold Insoluble Precipitate
Wash 0C
Add 10 mL cold CSH buffer
Drain
Cold Insoluble Precipitate
Resolubilize 37C, 5 min Add 2mL CSH buffer
Spin 3,700 x g, 6 min
Factor VIII3 rich solution
Debris
Represents a pool of 6 units of plasma
3 Total FVIII 1,017 units Total Fibrinogen 384
MG Total Protein 1,220 MG
22
  • In vivo effectiveness of a high yield Factor VIII
    concentrate prepared in a blood bank. New Engl.
    J. Med.
  • 1984 311 310-13.
  • Rock et al

23
IN VIVO
  • Heparin CRC (IP)
  • 90 recovery _at_ 15
  • ½ life 5.8 hrs
  • FPA lt 2.5 ng/ml
  • TT 3 sec x 1 hr
  • PTT 81 to 49 _at_ 1 hr

24
NEJM 1984
25
1300 U FVIII/L
  • I
  • 10 u/ml
  • 68
  • 52
  • 560 U/L 43
  • II
  • 2 u/ml
  • 66
  • 45
  • 40 523 U/L

PLASMA
CRYO I
CRYO II
SUPER
1.9 U/mg ptn more R.Cof vWF
1.5 U/mg ptn
26
STERILIZE
  • Product Final stages
  • Plasma SDP
  • Me blue
  • psoralens
  • riboflavin

27
ASSAYS
  • Heparin
  • Citrate

28
(No Transcript)
29
  • Yes
  • Possible
  • Cheaper/relative
Write a Comment
User Comments (0)
About PowerShow.com